EAEkaterina N. Amansakhatova

Ekaterina N. Amansakhatova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekaterina N. Amansakhatova has a total of 81 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Surgical Management of Congenital Heart Disease in the Russian Federation for 2025.

    by Ilya A. Soynov, Alexey I. Kim, Ruben Rudolfovich Movsesyan, Pavel Viktorovich Teplov, Aleksandr Yu. Miller, Yuriy Yu. Kulyabin, Aleksey N. Arkhipov, Anton A. Avramenko, Kirill V. Gorbatikov, Artem V. Gorbatykh, et al.

    Introduction: Systematic monitoring of outcomes in patients with congenital heart disease (CHD) is essential for improving the quality of care. Since 2024, a national multicenter digital registry designed to consolidate data from the country’s leading expert centers has been undergoing pilot implementation in the Russian Federation. Objective: To assess surgical volumes, the distribution of diagnoses, and in-hospital mortality associated with treatment for CHD and cardiac arrhythmias in the Russian Federation using 2025 registry data. Methods: We retrospectively analyzed de-identified data from 15,634 patients treated at 32 cardiac surgery centers in the Russian Federation that provide care to patients younger than 18 years with CHD. Procedural complexity was assessed using the RACHS II risk-stratification system. Outcomes were analyzed by age group, including neonates with low birth weight. Results: Overall in-hospital mortality was 1.30% (vs. 1.42% in 2024). Open surgical procedures accounted for 48.3% of interventions, transcatheter procedures for 37.6%, and procedures for cardiac arrhythmias for 12.8%. The most common CHD diagnoses were atrial septal defect (23.96%), patent ductus arteriosus (22.42%), and ventricular septal defect (15.47%).The highest mortality was observed among neonates undergoing surgerywith cardiopulmonary bypass (9.5%). Conclusion: The 2025 data confirm a sustained decline in overall mortalityand support the effectiveness of implementing national standards. Further improvement in neonatal surgery for complex defects remains a priority. Implementation of a unified system enabling patient-level identification and personalized assessment of treatment effectiveness is also essential. Received 8 July 2026. Revised 12 July 2026. Accepted 20 August 2026. Funding The study did not have sponsorship. Conflict of InterestThe authors declare no conflict of interest. Contribution of the authorsConception and study design: I.A. Soynov, R.R. Movsesyan, P.V. Teplov, A.A. Svobodov, E.V. Krivoshchekov, E.S. Tarasyuk Data collection and analysis: I.A. Soynov, A.Yu. Miller, Yu.Yu. Kulyabin, A.N. Arkhipov, A.A. Avramenko, K.V. Gorbatikov, A.V. Gorbatykh, K.A. Nalimov, S.A. Kovalev, A.A. Svobodov, A.A. Shikhranov, M.V. Plotnikov, O.A. Egunov, V.A. Belov, I.V. Gladyshev, K.B. Kazantsev, O.Yu. Kornoukhov, A.V. Nokhrin, D.Yu. Petrushenko, E.S. Efanov, I.K. Khalivopulo, D.V. Ryabtsev, Yu.A. Sobolev, V.N. Medvedev, R.Yu. Gavrilov, N.I. Pavlov Statistical analysis: I.A. Soynov, P.V. Teplov, K.A. Nalimov, M.A. Abramyan, S.A. Kovalev Drafting the article: I.A. Soynov, A.Yu. Miller, Yu.Yu. Kulyabin, A.A. Avramenko, K.V. Gorbatikov, A.V. Gorbatykh, K.A. Nalimov, A.V. Kauk, E.V. Krivoshchekov, E.N. Amansakhatova Critical revision of the article: A.I. Kim, R.R. Movsesyan, M.A. Abramyan, E.V. Krivoshchekov, E.S. Tarasyuk Final approval of the version to be published: all authors

  • Open Access

    Surgical and endovascular treatment methods for aortic coarctation in patients of different age groups (literature review)

    by S. A. Magbulova, K. A. Rzaeva, A. V. Voitov, E. N. Amansakhatova, I. A. Soynov, С. А. Магбулова, К. А. Рзаева, А. В. Войтов, Е. Н. Амансахатова, И. А. Сойнов

    Introduction. Coarctation of the aorta (CoA) remains one of the most common congenital heart defects, associated with a high incidence of cardiovascular complications even after successful correction. Despite advances in both endovascular and surgical repair techniques, there is no unified approach to selecting the optimal treatment strategy, and the available data on long-term postoperative outcomes require systematic synthesis. Aim: To analyze current data on the surgical and endovascular treatment of CoA in patients of different age groups, to characterize the anatomical features of the congenital defect, the technical aspects of interventions, immediate and long-term treatment outcomes, as well as to assess the incidence of complications and reinterventions. Material and Methods. A literature search was performed using the electronic databases eLibrary.ru and PubMed. The study included articles published between 2014 and 2026. A total of 1,331 publications on aortic coarctation were screened. Ultimately, 52 studies were included in the final review. Results. Analysis of the included publications showed that surgical correction remains the “gold standard” in neonates and young children, whereas endovascular repair is preferred in adolescents and adults. In the long term, neither of these strategies completely eliminates risks: the potential for arterial hypertension, recoarctation, aneurysm formation, and the need for repeat interventions persists. Conclusion. The choice of treatment strategy for aortic coarctation should be individualized, taking into account the patient's age, the anatomy of the narrowing, and the technical capabilities of the medical center. However, all patients, regardless of the correction method, require lifelong dynamic follow-up with regular blood pressure monitoring and aortic imaging for timely detection and management of long-term postoperative complications.

  • Open Access

    role of early unifocalization in the correction of pulmonary atresia with ventricular septal defect: the retrospective analysis

    by Ekaterina N. Amansakhatova, Yuriy Yu. Kulyabin, Alexey V. Voitov, Nataliya R. Nichay, Alexey N. Arkhipov, Ilya A. Soynov

    Introduction: The presence of multifocal pulmonary blood flow in pulmonary atresia with ventricular septal defect plays a critical role in determining the strategy for surgical correction. Early unifocalization of the pulmonary arterial bed facilitates achievement of complete repair with physiological right ventricular pressure. Objective: To evaluate the effectiveness of pulmonary artery reconstruction with unifocalization to achieve radical correction in pulmonary artery atresia with interventricular defect and multifocal pulmonary flow. Methods: This study involved 25 patients with pulmonary atresia and ventricular septal defect types B and C (according to the classification of C.Tchervenkov), who underwent unifocalization of the pulmonary bed. In accordance with age at the time of correction, all patients were divided into two groups: Group EU (early unifocalization, n = 11) – patients operated on at the age of up to 1 year, Group LU (late unifocalization, n = 14) – patients operated on at the age of over 1 year. The primary endpoint was successful complete repair with maintenance of right ventricular pressure at less than two-thirds of systemic pressure. The secondary endpoints included the rates of reintervention, freedom from reoperation, incidence of residual pulmonary hypertension, and rate of adverse outcomes. Results: The age of patients in the groups with early and late unifocalization of the pulmonary bed was 6.0 (0; 11) and 90.5 (13; 132) months. Pulmonary hypertension in the preoperative period was diagnosed in 1 patient (9 %) in the EU group, and in 11 patients (79 %) in the LU group (p = 0.001). Radical correction and right ventricular pressure less than 2/3 of the systemic pressure were achieved more often in patients in group EU than in group LU (73 % vs. 29 %, р = 0.04 and 89 % vs. 38 %, p = 0.03). Repeated transcatheter interventions and surgical redo procedures were required more often in patients from group LU (85 %, р = 0.02, 85 %, р = 0.007). There were no statistically significant differences in early and long-term mortality rates between the groups (p = 1.0). Conclusion: Early unifocalization of pulmonary blood flow allows achievingoptimal parameters for achieving radical correction of the defect. After radical correction, most patients who underwent unifocalization at an early age retain low pressure in the right ventricle in the long term and are less susceptible to repeated interventions. Received 28 November 2024. Revised 25 September 2025. Accepted 30 January 2026. FundingThe research was carried out within the framework of the state assignment of the Ministry of Health of the Russian Federation (No. 124022500251-0). Conflict of interest The authors declare no conflict of interest. Contribution of the authorsConception and study design: E.N. Amansakhatova, Yu.Yu. Kulyabin, A.V. Voitov, N.R. Nichay, A.N. Arkhipov Data collection and analysis: E.N. Amansakhatova, A.V. Voitov, N.R. Nichay, A.N. Arkhipov Statistical analysis: E.N. Amansakhatova, Yu.Yu. Kulyabin, N.R. Nichay, I.A. Soynov Drafting the article: E.N. Amansakhatova, Yu.Yu. Kulyabin, I.A. Soynov Critical revision of the article: Yu.Yu. Kulyabin, N.R. Nichay, A.N. Arkhipov, I.A. Soynov Final approval of the version to be published: all authors

  • Open Access

    Surgical management of congenital heart diseases in the Russian Federation: national registry data for 2024

    by Ilya A. Soynov, Алексей Иванович Ким, Ruben R. Movsesyan Movsesyan, Павел Викторович Теплов, Александр Юрьевич Миллер, Yuriy Yu. Kulyabin, Анон Алексеевич Авраменко, Кирилл Виктрович Горбатиков, Artem V. Gorbatykh, Константин Александрович Налимов, et al.

    Introduction. Congenital heart diseases (CHDs) remain a leading cause ofinfant mortality and disability, underlining their high medico-social significance.In the context of rapid technological advancements, evolving demographicindicators, and improvements in prenatal diagnostics, systemic monitoring of treatment outcomes at the national level has become critically important. The national registry facilitates an objective assessment of current cardiac surgical care effectiveness nationwide, helps identify regional trends, and determines priority areas for the implementation of modern hybrid and endovascular protocols. Objective. To evaluate the current status and outcomes of surgical treatment for congenital heart diseases (CHD) in the Russian Federation based on the 2024 national multicenter registry data. Methods. A retrospective analysis of 14,640 surgical procedures performed across 31 cardiac surgery centers was conducted. The RACHS II scoring system was utilized for risk stratification. The study assessed hospital mortality rates, pathology distribution, and the efficacy of various surgical strategies. Results. The overall hospital mortality rate was 1.42 %. Endovascular procedures accounted for a significant proportion (38.4 %) of interventions. In the interventional arrhythmia segment (n = 1,342), zero mortality was achieved. The highest risk remains in the neonatal group (6.6 % mortality). Analysis of palliative care revealed the superiority of the hybrid approach: ductal stenting in duct-dependent patients showed half the mortality rate (4.95 %) compared to the surgical systemic-to-pulmonary artery shunt (9.74 %). Complex reconstructions (Norwood procedure) remain a high-risk area. Conclusion. The national pediatric cardiac surgery registry demonstrates high efficacy and safety for routine interventions. There is a distinct trend towards replacing open surgery with endovascular techniques. Centralization of care for critical CHDs in expert centers and the adoption of hybrid technologies are key factors for further improving outcomes.


  • Open Access

    Early and long-term outcomes of aortic coarctation repair: a prospective two-center study

    by Павел Викторович Теплов, Егор Михайлович Гвоздь, Alexandr Miller, Yliya N. Polyakova, Валерий Анатольевич Сакович, Екатерина Назаровна Амансахатова, Iliya A. Soynov, Юлия Николаевна Полякова, Илья Алексндрович Сойнов

    Introduction. Recoarctation of the aorta, arterial hypertension and main bronchus compression remain the major complications following surgical correction of aortic coarctation and aortic arch hypoplasia, despite high effectiveness and low mortality in most patients. Objective. To evaluate early and long-term outcomes of surgical treatment in neonatal patients with aortic coarctation, comparing native tissue repair (such as extended end-to-end anastomosis) to patch aortoplasty techniques. Methods. This two-center, prospective, randomized study analyzed the outcomes of surgical repair for aortic coarctation with arch hypoplasia in a pediatric patient cohort, which included 105 neonates. According to the study design, all patients were divided into two groups based on the surgical technique used: patch aortoplasty (70 patients) and repair with an extended end-to-end anastomosis (35 patients). Results. In-hospital mortality in the patch repair group was 5 (7.1 %) patients, compared to 3 (8.6 %) patients in the native tissue repair group, p > 0.999. The only independent risk factor for mortality, regardless of the surgical technique performed, was the duration of cardiopulmonary bypass (OR with 95 % CI 1.374 to 45.242, p = 0.016). The sole predictor for the development of aortic recoarctation in the long-term postoperative period was a peak gradient across the isthmus exceeding 14 mm Hg (HR = 3.75; p < 0.001). The use of the patch repair surgical strategy was associated with a reduced risk of developing arterial hypertension (HR = 0.385, p = 0.046). Conclusion. Both common surgical strategies demonstrate comparable efficacy in treating coarctation and hypoplasia of the aortic arch in newborns. Regardless of the surgical approach, primary attention should be paid to the individual anatomical features of the aortic arch, patient condition, and associated congenital heart defects. However, in all patients, complete resection of ductal tissue is mandatory to prevent the development of aortic recoarctation and residual arterial hypertension.

  • Open Access

    Ten years of experience with total perfusion for cerebral and end-organ protection during aortic arch reconstruction in neonates

    by Ilya A. Velukhanov, Ekaterina N. Amansakhatova, Илья Викторович Бондаренко, Ольга Сергеевна Аникина, Yuriy Yu. Kulyabin, Alexey N. Arkhipov, Alexey V. Voitov Voitov, Виктор Яковлевич Мартыненков, Valery A. Nepomnyashchy, Игорь Анатольевич Корнилов, et al.

    Introduction. Whole-body perfusion represents a promising alternative to traditional methods, such as deep hypothermic circulatory arrest and antegrade cerebral perfusion, potentially reducing the risks of both neurological complications and acute kidney injury. However, the experience with its application, especially in the most vulnerable group of neonates, remains insufficiently studied and requires systematic analysis of intraoperative and longterm outcomes. Objective. To evaluate intraoperative and early postoperative outcomes in neonates undergoing aortic arch reconstruction with whole-body perfusion. Methods. This prospective cohort study evaluated the efficacy and safety of surgical treatment in neonates undergoing aortic arch reconstruction with total perfusion (n = 43). The median patient age was 8 (IQR 5–28) days, and median body weight was 3.4 (IQR 2.9–4) kg. Male patients predominated 25 (58.2 %). Results. The primary endpoint was acute kidney injury assessed using the pediatric KDIGO criteria. Acute kidney injury was observed in 9 (21 %) of patients. The only significant factor for acute kidney injury was the inotropic index on postoperative day 1 (OR = 1.08; 95 % CI (1.01; 1.17)). Neurological complications occurred in 4 (9.3 %) of patients. Hospital mortality was 1 (2.3 %). Conclusion. Whole-body perfusion represents a straightforward, efficacious, and safe organ protection strategy for neonatal aortic arch reconstruction, demonstrating a low rate of acute kidney injury.


  • Open Access

    THE 1st STAGE OF HEMODYNAMIC STRATEGIES FOR MANAGEMENT OF HYPOPLASTIC LEFT HEART SYNDROME

    by Ekaterina N. Amansakhatova, Ilya A. Soynov, Yuriy Yu. Kulyabin, Nataly R. Nichay, Kseniya A. Rzaeva, Olga S. Anikina, Ilya A. Velyukhanov, Alex N. Arkhipov, Екатерина Назаровна Амансахатова, Илья Александрович Сойнов, et al.

    Highlights The research presented in this paper evaluates the alternatives for the 1 st stage of hemodynamic correction of HLHS, outlines possible complications that may emerge in the postoperative phase, and provides approaches for their overcome in the intraoperative period. Abstract Hypoplastic left heart syndrome (HLHS) is a congenital heart disease that describes in the underdevelopment of the left-sided structures of the heart. HLHS is a rare defect in infants born and occurs in 2–3% of all congenital heart diseases. Primary heart transplantation demonstrates a radical correction of HLHS. However, a shortage of organs and a prohibition on this procedure to juvenile make it unavailable. Therefore, this review presents options for surgical correction of newborns with hypoplastic left heart syndrome, their advantages and disadvantages, as well as possible complications.

  • Open Access

    Assessment of the diagnostic potential of transpulmonary thermodilution in young children after radical correction of tetralogy of Fallot

    by Илья Викторович Бондаренко, Владимир Владимирович Ломиворотов, Ilya A. Velukhanov, Александра Алексеевна Кривошапкина, Ekaterina N. Amansakhatova, Valery A. Nepomnyashchy, Виктор Яковлевич Мартыненков, Ilya A. Soynov, Илья Алексеевич Велюханов, Валерий Анатольевич Непомнящих, et al.

    Background: In congenital heart surgery, in particular upon the radical correction of tetralogy of Fallot in children aged up to 1 year, hemodynamic indicators determined routinely often do not enable to assess in full the individual hemodynamic profile of the patient and to develop an individualized protocol for targeted hemodynamic therapy. This circumstance stipulates the use of advanced hemodynamic monitoring, and specifically the transpulmonary thermodilution (PiCCO) technique. However, the use of this technique is limited by the lack of reference values for patients with this nosological form and in this specific age group. Objective: The study was aimed at determining reference indicators of transpulmonary thermodilution in children aged up to 1 year after radical correction of Tetralogy of Fallot to develop protocols of targeted hemodynamic therapy. Methods: This prospective cohort study was based on the transpulmonary thermodilution data of 30 patients aged up to 1 year after radical correction of Tetralogy of Fallot performed at the Meshalkin National Medical Research Center of the Ministry of Health of Russia from 2019 to 2022. Results: Right ventricular failure developed in 11 patients (36.7%). A risk factor for right ventricular dysfunction was pulmonary regurgitation of grade 2 or higher, which developed in 14 patients (46.7%). The average regurgitation volume was 18.8 (12.1; 19.5) ml. According to the PiCCO data, no right ventricular failure was detected in children in the early postoperative period. Conclusion: Standard hemodynamic monitoring parameters using the PiCCO system, recommended for adult patients, cannot be applied to children, especially tender-age infants, after radical correction of tetralogy of Fallot. Transpulmonary thermodilution parameters do not enable to detect right ventricular failure after radical correction of tetralogy of Fallot in children aged up to 1 year.

  • Open Access

    Extracorporeal support for right ventricular failure following LVAD implantation in a 5-year-old child: a case report

    by E. N. Amansakhatova, I. A. Velyukhanov, I. A. Soynov, O. S. Anikina, Yu. Yu. Kulyabin, A. N. Arkhipov, V. A. Nepomnyashchikh, V. Ya. Martynenkov, I. A. Kornilov, A. M. Chernyavsky, et al.

    Introduction. Postoperative right ventricular failure is a dangerous adverse event in patients after left ventricular assist device (LVAD) implantation. The survival rate of such patients is extremely low. The only strategy that enables patient survival after LVAD implantation is the use of extracorporeal membrane oxygenation (ECMO) to bypass the right ventricle. The objective was to present a case report on the management of right ventricular failure (RVF) following left ventricular assist device (LVAD) implantation in a 5-year-old child, utilizing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a right ventricular bypass strategy. Results. Serial echocardiographic assessment under ECMO support revealed progressive RV functional recovery, with FAC increasing from 7% to 28% and TR decreasing from 50% to 15% by postoperative day 10. The patient was successfully weaned from ECMO on day 14 with preserved RV function (FAC 30%, grade 1 TR). Conclusion. The use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a right ventricular bypass strategy provides hemodynamic stabilization, improves oxygenation, and creates optimal conditions for myocardial recovery. This case report demonstrates the efficacy of a gradual ECMO weaning protocol under echocardiographic guidance, which may prove valuable in managing similar clinical scenarios.

  • Staged treatment of a patient with anomalous origin of the occluded left pulmonary artery from innominate artery

    by E.N. Amansakhatova, D.S. Zemel, S.N. Manukyan, Yu.Yu. Kulyabin, I.A. Soynov, A.V. Voitov

    Ductal origin of one pulmonary artery from ascending aorta is a rare anomaly whose incidence does not reach 0.12% of all congenital heart defects. It is often combined with other congenital heart defects, such as ventricular and atrial septal defects, tetralogy of Fallot, vascular ring, aortopulmonary window and patent ductus arteriosus. We present successful step-by-step correction of anomalous origin of the occluded left pulmonary artery from the innominate artery in a newborn.